Nearly 1 million people in the U.S. are living with MS – double the number from just a few decades ago. This unpredictable disease of the central nervous system can lead to long-term disabilities and has no known cure. With the COVID-19 crisis putting people with chronic illnesses especially at risk, making strides toward a cure is more important than ever.
At Fidelity Life, we’ve been committed to supporting the needs of everyday Americans since 1896. When it comes to MS, we believe there’s no better way to stop it in its tracks than to work together. We hope that the next chapter in the MS story will be the last.
That’s why Fidelity Life was proud to partner with The National MS Society, the largest private organization supporting MS research globally, to participate in virtual Walk MS on May 30, 2020. We even created our own National MS Society Team so our employees could help raise funds and awareness for this worthy cause.
We’re also proud to announce that we were recently named “Top Overall Corporate Team” by the National MS Society for our fundraising efforts prior to and during the event. We’re thrilled to be recognized for our contribution to this deserving organization. During the pandemic, raising funds to find a cure is even more crucial.
“While our support for MS research might look different than usual this year, our mission remains the same,” says Jim Harkensee, President of Fidelity Life. “We’re privileged to partner with The National MS Society, and we appreciate the dedication of all our employees who are volunteering their time and efforts to this worthy cause.”
MS won’t stop because of COVID-19 – and we won’t, either. Those with MS need us now more than ever to join together and fight for an end to MS. Follow Fidelity Life on Facebook, LinkedIn, and Instagram to see how our team is stepping up in search of a cure, and visit our Walk MS team page to learn how you can help close the book on MS for good.